Ocular Hypotony

Ocular Hypotony

No Results

No Results


Hypotony is usually defined as an intraocular pressure (IOP) of 5 mm Hg or less. Low IOP can adversely impact the eye in many ways, including corneal decompensation, accelerated cataract formation, maculopathy, and discomfort. Clinically significant changes occur more frequently as the IOP approaches 0 mm Hg.

The usual rate of aqueous humor production and outflow is 2.5 µL/min. In healthy human eyes, most aqueous humor exits through the conventional trabecular meshwork/juxtacanalicular/Schlemm canal/episcleral venous route. The remaining 10-40% exits via the uveoscleral outflow, where it crosses the ciliary body, sclera, or scleral openings to reach the suprachoroidal space. Flow through the trabecular route ceases when IOP declines below the episcleral venous pressure, usually 9 mm Hg. Therefore, uveoscleral outflow predominates at low IOPs.

Hypotony occurs when aqueous humor production does not keep pace with outflow. Outflow may be greater than usual, as seen with wound leak, overfiltering bleb, or cyclodialysis cleft. Conditions that decrease ciliary body function, such as iridocyclitis, hypoperfusion, or tractional ciliary body detachment, may cause inadequate aqueous humor production. Hypotony is also seen in association with rhegmatogenous retinal detachments and some altered osmotic states.

Inflammation plays a key role in the evolution of hypotony. It causes increased permeability of the blood-aqueous barrier and impairs ciliary body aqueous production. Choroidal fluid is believed to accumulate in its potential space as a result of a relative increase in uveoscleral outflow and the lack of sufficient IOP to maintain closure of the space. This cycle is often perpetuated once choroidal effusions develop.

If an anterior ring of choroidal fluid rotates the ciliary body forward, malposition or detachment could contribute to decreased aqueous production. Whether decreased aqueous production in the setting of choroidal effusion can occur without a component of inflammation is unclear. Hypotony itself seems to potentiate breakdown of the blood-aqueous barrier, making breaking the cycle difficult.

Primate studies show impaired axoplasmic flow in the optic nerve head during extremes of both high and low IOP, suggesting that progressive optic neuropathy can result from hypotony. [1]

United States

Hypotony following glaucoma surgery is common but is often not clinically significant. Transient hypotony can develop after other types of ocular surgery, especially if a pars plana approach has been used, or following trauma. The rate of hypotony following uncomplicated cataract surgery is extremely low. The incidence of hypotony associated with trabeculectomy increases with the use of antifibrinolytic agents. In the MUST trial, 8.3% of patients with uveitis had hypotony at baseline. [2] Chronic hypotony leading to phthisis is rare and occurs only in eyes with severe damage or complex problems.

Hypotony usually occurs as a complication of an underlying ocular disorder, trauma, or surgery.

Transient or permanent visual impairment may result from hypotony, especially if chronic or severe. Refractory hypotony may result in phthisis.

Females may be more predisposed to hypotony following antimetabolite-enhanced trabeculectomy. Males may be more prone to hypotony maculopathy. [3]

Young patients with myopia may be more predisposed to hypotony following trabeculectomy.

Transient hypotony after glaucoma surgery or a blunt injury in an otherwise healthy eye has an excellent prognosis. Eyes with underlying inflammatory or ischemic disease that develop chronic refractory hypotony have a guarded prognosis and may progress to phthisis. 

Patients should be educated about the cause and the implications of this condition. Better understanding may help the patient to be more compliant with treatment and follow-up care. Patients should also be warned of the potential chronicity of hypotony. Improvement in visual acuity often lags behind the resolution of hypotony.

Emphasize activity limitations, use of eye shield, compliance with medications, and increased fluid intake.

Encourage patients to contact their provider if their situation seems to be worsening.

Anderson DR, Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol. 1974 Oct. 13 (10):771-83. [Medline].

Sen HN, Drye LT, Goldstein DA, et al. Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm. 2012 Apr. 20(2):104-12. [Medline].

Thomas M, Vajaranant TS, Aref AA. Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods. Ophthalmol Ther. 2015 Dec. 4 (2):79-88. [Medline].

Bourgault S, Tourville E. Incidence of postoperative hypotony in 25-gauge vitrectomy: oblique versus straight sclerotomies. Can J Ophthalmol. 2012 Feb. 47(1):21-3. [Medline].

Hoguet A, Parrish RK 2nd. Unexpected hypotony after glaucoma drainage implant surgery associated with anti-vascular endothelial growth factor treatment. JAMA Ophthalmol. 2015 Mar. 133 (3):349-50. [Medline].

Goldich Y, Cooper M, Barkana Y, Tovbin J, Lee Ovadia K, Avni I, et al. Ocular anterior segment changes in pregnancy. J Cataract Refract Surg. 2014 Nov. 40 (11):1868-71. [Medline].

Rosa N, Lanza M, Borrelli M, De Bernardo M, Palladino A, Di Gregorio MG, et al. Low intraocular pressure resulting from ciliary body detachment in patients with myotonic dystrophy. Ophthalmology. 2011 Feb. 118(2):260-4. [Medline].

Hammer ME, Grizzard WS. Endoscopy for evaluation and treatment of the ciliary body in hypotony. Retina. 2003 Feb. 23(1):30-6. [Medline].

Ganteris-Gerritsen E, Ugahary LC, Jansen J, Mulder PG, Cohen AF, van Meurs JC. Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis, or penetrating trauma. Retina. April 2012. 32:742-7.

Kiranmaye T, Garudadri CS, Senthil S. Role of oral doxycycline and large diameter bandage contact lens in the management of early post-trabeculectomy bleb leak. BMJ Case Rep. 2014 Dec 5. 2014:[Medline].

Aminlari A, Callahan CE. Medical, laser, and surgical management of inadvertent cyclodialysis cleft with hypotony. Arch Ophthalmol. 2004 Mar. 122(3):399-404. [Medline].

Ioannidis AS, Barton K. Cyclodialysis cleft: causes and repair. Curr Opin Ophthalmol. 2010 Mar. 21(2):150-4. [Medline].

Eha J, Hoffmann EM, Pfeiffer N. Long-term results after transconjunctival resuturing of the scleral flap in hypotony following trabeculectomy. Am J Ophthalmol. 2013 May. 155(5):864-9. [Medline].

Quaranta L, Riva I, Floriani IC. Outcomes of conjunctival compression sutures for hypotony after glaucoma filtering surgery. Eur J Ophthalmol. 2013 Jul-Aug. 23(4):593-6. [Medline].

Abdalrahman O, Rodriguez AE, Alio Del Barrio JL, Alio JL. Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report. Eur J Ophthalmol. 2018 Oct 7. [Medline].

Fakhraie G, Mohajernezhad-Fard Z, Moghimi S, Vahedian Z, Eslami Y, Zarei R. Lens Extraction for Management of Coexisting Cataract and Post-filtering Surgery Ocular Hypotony. J Ophthalmic Vis Res. 2015 Oct-Dec. 10 (4):385-90. [Medline].

Sarkisian SR Jr. Tube shunt complications and their prevention. Curr Opin Ophthalmol. 2009 Mar. 20(2):126-30. [Medline].

Ciulla TA, Cantor LB, Kurz DE, Capistrano A. Laser trabecular sclerosis for chronic hypotony after vitreoretinal surgery. Ophthalmology. 2004 Feb. 111(2):256-8. [Medline].

Chan CC, Holland EJ, Sawyer WI, Neff KD, Petersen MR, Riemann CD. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes. Cornea. 2011 Oct. 30(10):1105-9. [Medline].

Stead RE, Juma Z, Turner S, Jones LD, Sung VC. A novel use of reticulated hyaluronic acid (Healaflow) for hypotony eyes in patients with uveitis. Br J Ophthalmol. 2016 Mar 25. [Medline].

Morphis G, Irigoyen C, Eleuteri A, Stappler T, Pearce I, Heimann H. Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months. Graefes Arch Clin Exp Ophthalmol. 2012 May. 250(5):645-52. [Medline].

Khaw PT, Chiang M, Shah P, Sii F, Lockwood A, Khalili A. Enhanced Trabeculectomy: The Moorfields Safer Surgery System. Dev Ophthalmol. 2017. 59:15-35. [Medline].

Budenz DL, Chen PP, Weaver YK. Conjunctival advancement for late-onset filtering bleb leaks: indications and outcomes. Arch Ophthalmol. 1999 Aug. 117(8):1014-9. [Medline].

Fine HF, Biscette O, Chang S, Schiff WM. Ocular Hypotony: A Review. Comprehensive Ophthalmology Update. Jan-Feb 2007. 8:29-37.

Georgoulas S, Dahlmann-Noor A, Brocchini S, Khaw PT. Modulation of wound healing during and after glaucoma surgery. Prog Brain Res. 2008. 173:237-54. [Medline].

Haynes WL, Alward WL. Control of intraocular pressure after trabeculectomy. Surv Ophthalmol. 1999 Jan-Feb. 43(4):345-55. [Medline].

Kunimoto DY, Kenitkar KD, Makar M. Hypotony. The Will’s Eye Manual. Lippincott, Williams, & Wilkins; 2004. 440-442.

Migdal C, Hitchings R. Morbidity following prolonged postoperative hypotony after trabeculectomy. Ophthalmic Surg. 1988 Dec. 19(12):865-7. [Medline].

Nicolela MT, Carrillo MM, Yan DB, Rafuse PE. Relationship between central corneal thickness and hypotony maculopathy after trabeculectomy. Ophthalmology. 2007 Jul. 114(7):1266-71. [Medline].

O’Connell SR, Majji AB, Humayun MS, de Juan E Jr. The surgical management of hypotony. Ophthalmology. 2000 Feb. 107(2):318-23. [Medline].

Pederson J. Ocular hypotony. Duane’s Ophthalmology. Lippincott Williams & Wilkins; 2011. Vol 3:

Ritch R, Shields MB, Krupin T. Ocular hypotony. The Glaucomas. 1996. Vol 3: 385-395.

Roters S, Szurman P, Engels BF, Bartz-Schmidt KU, Krieglstein GK. Ultrasound biomicroscopy in chronic ocular hypotony: its impact on diagnosis and management. Retina. 2002 Oct. 22(5):581-8. [Medline].

Schubert HD. Postsurgical hypotony: relationship to fistulization, inflammation, chorioretinal lesions, and the vitreous. Surv Ophthalmol. 1996 Sep-Oct. 41(2):97-125. [Medline].

Suner IJ, Greenfield DS, Miller MP, Nicolela MT, Palmberg PF. Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology. 1997 Feb. 104(2):207-14; discussion 214-5. [Medline].

Bitrian E, Song BJ, Caprioli J. Bleb revision for resolution of hypotony maculopathy following primary trabeculectomy. Am J Ophthalmol. 2014 Sep. 158 (3):597-604.e1. [Medline].

Sheila P Sanders, MD Associate Professor, Director of Glaucoma Service, Department of Ophthalmology, University of Kentucky College of Medicine

Sheila P Sanders, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

Joshua W Evans, MD Resident Physician, Department of Ophthalmology, University of Kentucky College of Medicine

Joshua W Evans, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, Kentucky Academy of Eye Physicians and Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

J James Rowsey, MD Former Director of Corneal Services, St Luke’s Cataract and Laser Institute

J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Sigma Xi, Southern Medical Association, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Hampton Roy, Sr, MD Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy, Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Bradford Shingleton, MD Assistant Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary

Bradford Shingleton, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Ocular Hypotony

Research & References of Ocular Hypotony|A&C Accounting And Tax Services